221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

about

221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

Item

http://www.wikidata.org/entity/Q63576117

description

clinical trial

@en

klinisch onderzoek

@nl

name

221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

@en

type

Item

label

221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

@en

prefLabel

221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

@en

P1132

1,605

http://www.w3.org/2001/XMLSchema#decimal

P1476

A Phase 3 Multicenter, Randomi ...... With Early Alzheimer's Disease

@en

P17

P1813

ENGAGE

@en

P2899

http://www.w3.org/2001/XMLSchema#decimal

P3098

NCT02477800

http://www.w3.org/2001/XMLSchema#string

P31

clinical trial

P4135

http://www.w3.org/2001/XMLSchema#decimal

P580

2015-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P582

2020-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase III clinical trial

P6153

Mayo Clinic

National Taiwan University Hospital

Indiana University – Purdue University Indianapolis

University of Rochester

Agostino Gemelli University Polyclinic

University of Edinburgh

State University of New York at Albany

University of Pittsburgh

University of Texas Southwestern Medical Center

Baylor College of Medicine